Skip to content
PubMed This is a summary of 6 peer-reviewed journal articles Updated
Nephrology

Diagnosis & Look-alike Conditions: Distinguishing Iminoglycinuria

At a Glance

Iminoglycinuria is diagnosed using a urine amino acid analysis that shows a selective loss of proline, hydroxyproline, and glycine. Because it is harmless, the main goal of diagnosis is to rule out more serious look-alike kidney conditions like Fanconi syndrome or Hartnup disorder.

When a lab report shows “amino acids in the urine,” it can be frightening. However, the process of diagnosing iminoglycinuria is focused on proving that the “spilling” is selective. Your doctor’s goal is to ensure that your kidneys are working perfectly in every other way and that only three specific building blocks—proline, hydroxyproline, and glycine—are slipping through the filter.

The Definitive Test: Urine Amino Acid Analysis

The most important tool for diagnosis is a urinary amino acid analysis (sometimes called chromatography) [1]. This test creates a detailed map of every amino acid exiting the body.

For a diagnosis of iminoglycinuria, the map must show a specific “triple” elevation of:

  1. Proline
  2. Hydroxyproline
  3. Glycine

Crucially, your doctor will often check a blood sample at the same time. In iminoglycinuria, the levels of these amino acids in your blood are perfectly normal [1]. This proves the problem isn’t that you have “too much” of them, but rather that your kidney is simply letting them go [2].

Distinguishing the “Look-Alikes”

Because iminoglycinuria is harmless, the most critical part of the diagnosis is ruling out other conditions that do require treatment. Doctors look for “clues” that separate these conditions.

1. Hartnup Disorder

Hartnup disorder also involves amino acids in the urine, but it affects a different group called neutral amino acids (like tryptophan) [3][4].

  • The Difference: In iminoglycinuria, the loss is limited to the “imino” group (proline/hydroxyproline) and glycine.
  • Why it matters: Hartnup disorder can sometimes cause skin rashes or neurological symptoms if not managed with niacin (Vitamin B3), whereas iminoglycinuria does not [1].

2. Fanconi Syndrome

Fanconi syndrome is a more serious condition where the entire “recycling center” of the kidney (the proximal tubule) breaks down.

  • The Difference: In Fanconi syndrome, the kidney loses everything—all amino acids, plus glucose (sugar), phosphate, and bicarbonate [1].
  • The “Rule-Out”: If your urine test shows only proline and glycine, and your glucose and phosphate levels are normal, Fanconi syndrome is effectively ruled out.

The “Age Rule” for Infants

If the patient is a newborn, a diagnosis of familial (genetic) iminoglycinuria cannot be made immediately. Almost all babies have physiological iminoglycinuria because their kidney transporters haven’t “switched on” yet [5][5].

  • The Timeline: This is a normal stage of growth and usually disappears by 6 months of age [5].
  • The Confirmation: If the amino acids are still present after the 6-month mark, doctors will then consider it the lifelong genetic version [5].

Is Genetic Testing Necessary?

While not always required, genetic testing can provide a final “yes” by identifying mutations in the SLC6A20 or SLC36A2 genes [2][6]. This can be particularly helpful if the urine results are unclear or if you want to understand if family members are carriers.

Return to the Home Page.

Common questions in this guide

How is iminoglycinuria diagnosed?
Doctors diagnose iminoglycinuria using a urine amino acid analysis. This test looks for specific elevations of proline, hydroxyproline, and glycine in the urine while blood levels of these amino acids remain completely normal.
What is the difference between iminoglycinuria and Fanconi syndrome?
While iminoglycinuria only involves the harmless loss of three specific amino acids, Fanconi syndrome is a more serious kidney issue. In Fanconi syndrome, the kidneys lose all amino acids, as well as essential nutrients like glucose and phosphate.
Why do newborns often test positive for iminoglycinuria?
Most newborns temporarily spill these amino acids in their urine because their kidney transporters are not fully developed yet. This is a normal stage of growth, known as physiological iminoglycinuria, and it typically resolves on its own by six months of age.
Is genetic testing needed to diagnose iminoglycinuria?
While not always required, genetic testing can definitively confirm a diagnosis by checking for mutations in the SLC6A20 or SLC36A2 genes. It is especially helpful if your urine test results are unclear or if you want to know if family members are carriers.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is the amino acid loss in the urine limited specifically to proline, hydroxyproline, and glycine, or are other amino acids present?
  2. 2.Were there any signs of glucose, phosphate, or protein in the urine that might suggest a broader kidney issue like Fanconi syndrome?
  3. 3.Given that infants often have this temporarily, should we repeat this test in a few months to see if it resolves on its own?
  4. 4.Do you recommend genetic testing for the SLC6A20 gene to distinguish this from other look-alike conditions?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (6)
  1. 1

    Amino Acid Transport Across the Mammalian Intestine.

    Bröer S, Fairweather SJ

    Comprehensive Physiology 2018; (9(1)):343-373 doi:10.1002/cphy.c170041.

    PMID: 30549024
  2. 2

    Structure and function of the SIT1 proline transporter in complex with the COVID-19 receptor ACE2.

    Li HZ, Pike ACW, Lotsaris I, et al.

    Nature communications 2024; (15(1)):5503 doi:10.1038/s41467-024-48921-x.

    PMID: 38951531
  3. 3

    The SLC6A15-SLC6A20 Neutral Amino Acid Transporter Subfamily: Functions, Diseases, and Their Therapeutic Relevance.

    Kukułowicz J, Pietrzak-Lichwa K, Klimończyk K, et al.

    Pharmacological reviews 2023; (76(1)):142-193 doi:10.1124/pharmrev.123.000886.

    PMID: 37940347
  4. 4

    Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors.

    Vuille-dit-Bille RN, Camargo SM, Emmenegger L, et al.

    Amino acids 2015; (47(4)):693-705 doi:10.1007/s00726-014-1889-6.

    PMID: 25534429
  5. 5

    Intestinal IMINO transporter SIT1 is not expressed in human newborns.

    Meier C, Camargo SM, Hunziker S, et al.

    American journal of physiology. Gastrointestinal and liver physiology 2018; (315(5)):G887-G895 doi:10.1152/ajpgi.00318.2017.

    PMID: 30160974
  6. 6

    Genetic mutation of SLC6A20 (c.1072T > C) in a family with nephrolithiasis: A case report.

    Jv M, Zheng J, Yang A, et al.

    Open medicine (Warsaw, Poland) 2023; (18(1)):20230648 doi:10.1515/med-2023-0648.

    PMID: 36820062

This page is for informational purposes only and does not replace professional medical advice. Always consult your healthcare provider or a genetic counselor to interpret your lab results and rule out other kidney conditions.

Get notified when new evidence is published on Iminoglycinuria.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.